Heart failure with preserved ejection fraction in coronavirus disease 2019 patients: the promising role of diuretic therapy in critically ill patients
Abstract The impact of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) on diastolic function is less known. We describe a 46‐year‐old man with a history of mild hypertension who presented to the emergency department with fever, cough, and myalgia for 2 days. The patient was tested posit...
Main Authors: | Mitra Chitsazan, Ahmad Amin, Mandana Chitsazan, Naghmeh Ziaie, Parviz Amri Maleh, Hamidreza Pouraliakbar, Stephan Von Haehling |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-04-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.13175 |
Similar Items
-
Six-Month Predictive Value of Diuretic Resistance Formulas in Discharged Heart Failure Patients after an Acute Decompensation
by: Mauro Feola, et al.
Published: (2020-09-01) -
Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction
by: Carolin Gehlken, et al.
Published: (2021-08-01) -
Combined Assessment of D-Dimer with the Get with the Guidelines—Heart Failure Risk Score and N-Terminal Pro-B-Type Natriuretic Peptide in Patients with Acute Decompensated Heart Failure with Preserved and Reduced Ejection Fraction
by: Hiroyuki Naruse, et al.
Published: (2021-08-01) -
Heart Failure with Preserved Ejection Fraction (HFpEF): A Case Report
by: Amanda Halimi, et al.
Published: (2021-09-01) -
Optimizing the discovery and assessment of therapeutic targets in heart failure with preserved ejection fraction
by: Gabrielle Fusco‐Allison, et al.
Published: (2021-10-01)